NCT00704964View on ClinicalTrials.gov

Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413)

CompletedOBSERVATIONAL
Enrollment

746

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Hepatitis CChronic Hepatitis C
Interventions
BIOLOGICAL

PegIntron

PegIntron (peginterferon alfa-2b) pen administered at a dose and frequency in accordance with approved labeling in Germany

DRUG

Rebetol

Rebetol (ribavirin) administered at a dose and frequency in accordance with approved labeling in Germany

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00704964 - Impact of Patient Support by the Medical Staff on Adherence to Therapy With PegIntron Plus Rebetol (Study P04413) | Biotech Hunter | Biotech Hunter